Abstract
Hakaru Hashimoto described 4 patients with a hitherto unknown cause for goitre, struma lymphomatosa, a century ago. He was careful to distinguish this from Riedel thyroiditis but it has become clear that fibrosis and atrophy of the thyroid are indeed components of Hashimoto thyroiditis, and in rare cases IgG4-related sclerosing disease may be an outcome. Although the cause of the lymphocytic infiltration was unknown to Hashimoto, we now know through the pioneering studies of N.R. Rose and E. Witebsky [J Immunol 1956;76:417–427] that this condition is the archetype for autoimmune destruction as a disease mechanism. In the last two decades in particular, there has been huge interest in unravelling the genetic basis for this and related autoimmune disorders. The list of polymorphisms associated with autoimmune thyroid disease grows each year, and in the case of vitiligo, which is frequently found in association with thyroid autoimmunity, we know that 27 separate susceptibility loci account for less than 20% of the heritability of this condition. Environmental and existential factors may turn out to be just as complex in number and in interactions. We can thus imagine a ‘Swiss cheese’ model for the causation of autoimmune thyroid disease, in which the effects of cumulative weaknesses line up – like the holes in slices of cheese – to allow the catastrophic event of autoimmune destruction to occur.
References
1.
Pinchera A, Pinchera MG, Stanbury JB: Thyrotropin and long-acting thyroid stimulator assays in thyroid disease. J Clin Endocrinol Metab 1965;25:189–208.
2.
Latrofa F, Ricci D, Montanelli L, Rocchi R, Piaggi P, Sisti E, et al: Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. J Clin Endocrinol Metab 2012;97:2380–2387.
3.
Hashimoto H: Zur Kenntis der lymphomatosen Veranderung der Schilddruse (Struma lymphomatosa). Arch Klin Chir 1912;97:219–248.
4.
Sawin CT: The heritage of Dr. Hakaru Hashimoto (1881–1934). Endocr J 2002;49:399–403.
5.
Zeher M, Horvath IF, Szanto A, Szodoray P: Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren’s syndrome. Thyroid 2009;19:39–45.
6.
Graham A, McCullagh E: Atrophy and fibrosis associated with lymphoid tissue in the thyroid; struma lymphomatosa (Hashimoto). Arch Surg 1931;22:548–567.
7.
Ord WM: Report of a committee of the Clinical Society of London nominated December 14, 1883, to investigate the subject of myxoedema. Trans Clin Soc Lond 1888;21.
8.
Murray GR: Diseases of the Thyroid Gland. London, HK Lewis, 1900.
9.
Rose NR, Witebsky E: Studies in organ specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J Immunol 1956;76:417–427.
10.
Picado C, Rotter W: Precipitines seriques antithyroidiennes chez le goitreux. Compte Rend Soc Biol 1936;123:1111.
11.
Stuart A: An origin of the term autoantibody. JR Coll Phys Edinb 2007;37:92–93.
12.
Rose NR: Autoimmunity: a personal memoir. Autoimmun 1988;1:15–21.
13.
Campbell PN, Doniach D, Hudson RV, Roitt IM: Auto-antibodies in Hashimoto’s disease (lymphadenoid goitre). Lancet 1956;271:820–821.
14.
Rose NR: The genetics of autoimmune thyroiditis: the first decade. J Autoimmun 2011;37:88–94.
15.
Silverman DA, Rose NR: Autoimmunity in methylcholanthrene-induced and spontaneous thyroiditis in Buffalo strain rats. Proc Soc Exp Biol Med 1971;138:579–584.
16.
Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, Husebye ES, et al: Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab 2012;97:1114–1124.
17.
Kisand K, Peterson P: Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome. Ann NY Acad Sci 2011;1246:77–91.
18.
d’Hennezel E, Bin Dhuban K, Torgerson T, Piccirillo C: The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2012;49:291–230.
19.
Hall R, Owen SG, Smart GA: Evidence for genetic predisposition to formation of thyroid autoantibodies. Lancet 1960;2:187.
20.
Brix TH, Kyvik KO, Hegedüs L: A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 2000;85:536–539.
21.
Weetman AP: The genetics of autoimmune thyroid disease. Horm Metab Res 2009;41:421–425.
22.
Davies TF: Really significant genes for autoimmune thyroid disease do not exist – so how can we predict disease? Thyroid 2007;17:1027–1029.
23.
Wiebolt J, Achterbergh R, den Boer A, van der Leij S, Marsch E, Suelmann B, et al: Clustering of additional autoimmunity behaves differently in Hashimoto’s patients compared with Graves patients. Eur J Endocrinol 2011;164:789–794.
24.
Lee HS, Kang J, Yang S, Kim D, Park Y: Susceptibility influence of a PTPN22 haplotype with thyroid autoimmunity in Koreans. Diab Metab Res Rev 2011;27:878–882.
25.
Park Y, Lee HS, Park Y, Min D, Yang S, Kim D, et al: Evidence for the role of STAT4 as a general autoimmunity locus in the Korean population. Diab Metab Res Rev 2011;27:867–871.
26.
Walsh JP, Berry J, Liu S, Panicker V, Dayan CM, Brix TH, et al: The clinical presentation of autoimmune thyroid disease in men is associated with IL12B genotype. Clin Endocrinol 2011;74:508–512.
27.
Chu X, Pan CM, Zhao SX, Liang J, Gao, GQ, Zhang XM, et al: A genome-wide association study identifies two new risk loci for Graves disease. Nat Genet 2011;43:897–901.
28.
Hardy J, Singleton A: Genome-wide association studies and human disease. N Engl J Med 2009;360:1759–1768.
29.
Wain LV, Armour JA, Tobin MD: Genomic copy number variation, human health, and disease. Lancet 2009;374:340–350.
30.
Spritz RA: Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. Thyroid 2010;20:745–754.
31.
Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, et al: Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 2010;362:1686–1697.
32.
Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, et al: Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet 2012;44:676–680.
33.
Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, Bruce CK, et al: Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves disease. Hum Mol Genet 2009;18:1704–1713.
34.
Brix TH, Hegedüs L: The complexity of the etiology of autoimmune thyroid disease is gravely underestimated. Thyroid 2011;21:1289–1292.
35.
Benvenga S, Trimarchi F: Changed presentation of Hashimoto’s thyroiditis in North-Eastern Sicily and Calabria (Southern Italy) based on a 31-year experience. Thyroid 2008:18;429–441.
36.
Ott J, Meusel M, Schultheis A, Promberger R, Pallikunnel SJ, Neuhold N, et al: The incidence of lymphocytic thyroid infiltration and Hashimoto’s thyroiditis increased in patients operated for benign goiter over a 31-year period. Virchows Arch 2011;459:277–281.
37.
Brent GA: Environmental exposures and autoimmune thyroid disease. Thyroid 2010;20:755–761.
38.
Swist E, Chen Q, Qiao C, Caldwell D, Gruber H, Scoggan KA: Excess dietary iodine differentially affects thyroid gene expression in diabetes, thyroiditis-prone versus -resistant BioBreeding (BB) rats. Mol Nutr Food Res 2011;55:1875–1886.
39.
Teng X, Shan Z, Chen Y, Lai Y, Yu J, Shan L, et al: More than adequate iodine intake may increase subclinical hypothyroidism and autoimmune thyroiditis: a cross-sectional study based on two Chinese communities with different iodine intake levels. Eur J Endocrinol 2011;164:943–950.
40.
Toulis KA, Anastasilakis AD, Tzellos TG, Goulis DG, Kouvelas D: Selenium supplementation in the treatment of Hashimoto’s thyroiditis: a systematic review and a meta-analysis. Thyroid 2010;20:1163–1173.
41.
Goswami R, Marwaha RK, Gupta N, Tandon N, Sreenivas V, Tomar N, et al: Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br J Nutr 2009;102:382–386.
42.
Effraimidis G, Tijssen JGP, Wiersinga WM: Alcohol consumption as a risk factor for autoimmune thyroid disease: a prospective study. Eur Thyroid J 2012;1:99–104.
43.
Gu JY, Qian CH, Tang W, Wu XH, Xu KF, Scherbaum WA, et al: Polychlorinated biphenyls affect thyroid function and induce autoimmunity in Sprague-Dawley rats. Horm Metab Res 2009;41:471–474.
44.
de Freitas CU, Grimaldi Campos RA, Rodrigues Silva MA, Panachão MR, de Moraes JC, Waissmann W, et al: Can living in the surroundings of a petrochemical complex be a risk factor for autoimmune thyroid disease? Environ Res 2010;110:112–117.
45.
Goldner WS, Sandler DP, Yu F, Hoppin JA, Kamel F, Levan TD: Pesticide use and thyroid disease among women in the Agricultural Health Study. Am J Epidemiol 2010;171:455–464.
46.
Bartalena L, Martino E, Marcocci C, Bogazzi F, Panicucci M, Velluzzi F, et al: More on smoking habits and Graves ophthalmopathy. J Endocrinol Invest 1989;12:733–737.
47.
Effraimidis G, Tijssen JG, Wiersinga WM: Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. J Clin Endocrinol Metab 2009:94;1324–1328.
48.
Agate L, Mariotti S, Elisei R, Mossa P, Pacini F, Molinaro E, et al: Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease. J Clin Endocrinol Metab 2008;93:2729–2736.
49.
Nagayama Y, Ichikawa T, Saitoh O, Abiru N: Induction of late-onset spontaneous autoimmune thyroiditis by a single low-dose irradiation in thyroiditis-prone non-obese diabetic-H2h4 mice. J Radiat Res 2009;50:573–577.
50.
Hamnvik OP, Larsen PR, Marqusee E: Thyroid dysfunction from antineoplastic agents. J Natl Cancer Inst 2011;103:1572–1587.
51.
Stefan M, Jacobson EM, Huber AK, Greenberg DA, Li CW, Skrabanek L, et al: Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. J Biol Chem 2011;286:31168–31179.
52.
Jørgensen KT, Pedersen BV, Nielsen NM, Jacobsen S, Frisch M: Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort. J Autoimmun 2011;38:J81–J87.
53.
Lepez T, Vandewoestyne M, Hussain S, Van Nieuwerburgh F, Poppe K, Velkeniers B, et al: Fetal microchimeric cells in blood of women with an autoimmune thyroid disease. PLoS One 2011;6:e29646.
54.
Effraimidis G, Tijssen JG, Brosschot JF, Wiersinga WM: Involvement of stress in the pathogenesis of autoimmune thyroid disease: a prospective study. Psychoneuroendocrinol 2012;37:1191–1198.
55.
Kondrashova A, Viskari H, Haapala AM, Seiskari T, Kulmala P, Ilonen J, et al: Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. J Clin Endocrinol Metab 2008;93:729–734.
56.
Cepon TJ, Snodgrass JJ, Leonard WR, Tarskaia LA, Klimova TM, Fedorova VI, et al: Circumpolar adaptation, social change, and the development of autoimmune thyroid disorders among the Yakut (Sakha) of Siberia. Am J Hum Biol 2011;23:703–709.
57.
Shapira Y, Agmon-Levin N, Shoenfeld Y: Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010;34:J168–J177.
58.
Mariotti S, Sansoni P, Barbesino G, Caturegli P, Monti D, Cossarizza A, et al: Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet 1992;339:1506–1508.
59.
Wang GC, Talor MV, Rose NR, Cappola AR, Chiou RB, Weiss C, et al: Thyroid autoantibodies are associated with a reduced prevalence of frailty in community-dwelling older women. J Clin Endocrinol Metab 2010;95:1161–1168.
60.
Kakudo K, Li Y, Hirokawa M, Ozaki T: Diagnosis of Hashimoto’s thyroiditis and IgG4-related sclerosing disease. Pathol Int 2011;61:175–183.
© 2012 European Thyroid Association Published by S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
